Ishizaki K, Nishizawa K, Kato T, Kitao H, Han Z B, Hirayama J, Suzuki F, Cannon T F, Kamigaichi S, Tawarayama Y, Masukawa M, Shimazu T, Ikenaga M
Central Laboratory and Radiation Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Aviat Space Environ Med. 2001 Sep;72(9):794-8.
Results of past space experiments suggest that the biological effect of space radiation could be enhanced under microgravity. To assess the radiation risk for humans during long-term spaceflight, it is very important to clarify whether human cells exhibit a synergistic effect of radiation and microgravity.
If significant synergism occurs in human cells, genetic changes induced during spaceflight may be detected by using human tumor HCT-116 cells which are hypermutable due to a defect in the DNA mismatch repair system.
Cultured HCT-116 cells were loaded on the Space Shuttle Discovery (STS-95) and grown during the 9-d mission. After landing, many single-cell clones were isolated, microsatellite repetitive sequences in each clone were amplified by PCR, and mutations in the microsatellite loci were detected as changes in the length of PCR fragments. Mutation frequencies of ouabain-resistant phenotype were also analyzed.
The frequencies of microsatellite mutations as well as ouabain-resistant mutations in the flight sample were similar to those of the ground control samples. Some cells were treated in space with bleomycin which mimics the action of radiation, but the frequencies of microsatellite mutations were not significantly different between the flight and the ground control samples.
Under the present flight conditions, neither space radiation (about 20 mSv during this mission) nor microgravity caused excess mutations in human cells.
过去的太空实验结果表明,在微重力条件下,太空辐射的生物学效应可能会增强。为了评估长期太空飞行期间人类面临的辐射风险,弄清楚人类细胞是否会表现出辐射与微重力的协同效应非常重要。
如果人类细胞中出现显著的协同作用,那么利用因DNA错配修复系统缺陷而具有高突变率的人类肿瘤HCT-116细胞,或许可以检测到太空飞行期间诱发的基因变化。
将培养的HCT-116细胞搭载在发现号航天飞机(STS-95)上,并在为期9天的任务中进行培养。着陆后,分离出许多单细胞克隆,通过聚合酶链反应(PCR)扩增每个克隆中的微卫星重复序列,并将微卫星位点的突变检测为PCR片段长度的变化。还分析了哇巴因抗性表型的突变频率。
飞行样本中的微卫星突变频率以及哇巴因抗性突变频率与地面对照样本相似。一些细胞在太空中用博来霉素处理,博来霉素模拟辐射作用,但飞行样本和地面对照样本之间的微卫星突变频率没有显著差异。
在当前的飞行条件下,太空辐射(此次任务期间约20毫希沃特)和微重力均未在人类细胞中导致过多突变。